Analysis of the transcriptomic features of microsatellite instability subtype colon cancer

BACKGROUND: Programmed cell death protein 1(PD-1) blocking antibodies have been used to enhance immunity in solid tumors and achieve durable clinical responses with an acceptable safety profile in multiple types of cancer. However, only a subset of patients could benefit from PD-1 blockade therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haiwei, Wang, Xinrui, Xu, Liangpu, Zhang, Ji, Cao, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585086/
https://www.ncbi.nlm.nih.gov/pubmed/31221124
http://dx.doi.org/10.1186/s12885-019-5802-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585086/
https://www.ncbi.nlm.nih.gov/pubmed/31221124
http://dx.doi.org/10.1186/s12885-019-5802-2

Ejemplares similares